Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Medicine Pharmaceutics > Biopharmaceutics > Flashcards

Biopharmaceutics Flashcards

1
Q

emptying stomach has around ____mL of gastric fluid

A

100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

if pH >pKa of an acid. ionisation?

A

99% ionised

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

If pH< pKa of an acid?

A

99% unionsed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Log P is _______ of pH

LogD is _______ of pH

A

independent

dependent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

effect of eating food on the stomach

A

increases gastric retention time and stimulates acid release, further reducing stomach pH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

LogP only measures the ______ form of the drug

A

ionised

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

LogD measures….

A

both ionised and non-ionised which is not affected by pH but the fraction ionised will depend on pH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

food ______ transit time of drugs in the stomach

A

increases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

if you have a poorly soluble drug you should take it when in relation to food?

A

WITH food

you will have a greater time for dissolution to occur.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how can dissolution be aided by our saliva for basic drugs?

A

saliva is acidic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is sink conditions?

A

• As drug molecules diffuse away from the saturated diffusion layer into the bulk fluids, new drug molecules replace them, rapidly saturating the diffusion layer (sink conditions)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the rate limiting step in sink conditions?

A

rate of dissolution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

where we have sink conditions what order kinetics are there?

A

first

[C] intestine >[C] blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

TF: the pH oft he diffusion layer around each particle is the same

A

no it can be different

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

if we don’t consider that the pH of the diffusion layer around each particle is different, what can happen?

A

we can overestimate rates of ionisation and dissolution of weak acids (intestines) and wet bases (stomach)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

the dissolution rate of weak acids in the stomach is _____. why

A

low

because the drug is unionised and therefore poorly soluble in the diffusion layer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

how can the pH of the diffusion layer be increased?

A

by forming an alkaline salt of the weak acid
Na and K salts dissolve more rapidly than free acids, regardless of the local pH as they release OH ions which promotes drug ionisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Na and K salts dissolve _____ rapidly than the free acids

A

MORE

release OH ions which promotes ionisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

TF: all small hydrophilic compounds permeate through paracellular water channels

A

false, not all do this. some do

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Log P is a measure of?

what is it

A

lipophilicity

the partition coefficient of an unionised drug between aq and lipophilic bases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what does the dissociation constant Ka or pKa describe?

A

the extent to which a drug is ionised

the pKa is the pH at which [ionised] = [unionised]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what is the pKa

A

the pKa is the pH at which [ionised] = [unionised]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what is the distribution coefficient?

A

the effective partition coefficient accounting for the degree of ionisation

WA
D= [HAorg]/ ([HAaq]+ [A-aq])

WB
D= [Borg]/ ([Baq]+[BH+aq])

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Distribution coefficient for weak acids equation

A

D= [HAorg]/ ([HAaq]+ [A-aq])

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Distribution coefficient for weak bases equation

A

D= [Borg]/ ([Baq]+[BH+aq])

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

D and LogD are pH ______

A

dependent

and they’re related to P

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

equation that relates LogD to LogP?

A

Log D = log P – log {1 + antilog (pKa - pH)}

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

what is the limitations with the Log D = log P – log {1 + antilog (pKa - pH)} equation when trying to determine logD?

A

. unstirred conditions, convective flow, absorption of ionised species, different pH at the membrane surface, disruption of the lipid membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

absorption rate equation?

A

Absorption rate = VmaxC/(Km+C)

C is the free (un-complexed) drug concentration at the site of absorption (ie GI luminal side of the bio membrane of the epithelial cell)
Km is a constant relating to the affinity of the carrier binding the drug (cf enzymes kinetics)
Vmax is a ‘constant’ relating to the maximum rate of transport or saturation of the carrier (cf enzyme kinetics)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

acidicy in the stomach effects a weak base drugs permeability and solubility how?

A

acidity increases % protonated and hence the solubility increases
charged base is less permeable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

when the weak base goes into the intestine what can happen in relation to solubility?

A

reduces % protonated as the pH increases

reduces solubility and a precipitate may form

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

the uncharged base is ______ lipophilic and permeable

A

more

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

acidicy in the stomach effects a weak acids drugs permeability and solubility how?

A

increases % uncharged acid
more lyophilic and permeable
decreased solubility- precipitate may form

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

when the weak acid goes into the intestine what can happen in relation to solubility?

A

reduces % uncharged acid
increases ionised and solubility
less lipophilic and lower partition into lipid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

what maintains a high diffusion tradition for solubilised and permeable fractions of the drug

A

rapid blood flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

what equation for weak acid is favoured in the stomach?

A

RCOO- + H+ –> RCOOH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

what equation for weak acid is favoured in the intestine?

A

RCOOH –> RCOO- + H+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

what equation for weak bases is favoured in the stomach?

A

RNH2 + H+ –> RNH3+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

what equation for weak bases is favoured in the intestine?

A

RNH3+ –> RNH2 + H+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

effects of food on drug solubility?

A

can change pH.

drug solubility differs by a factor of 100 over pH range 1-3 hence can cause variable absorption.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

if a formulation demonstrates excellent release characteristics at a gastric pH, then a decreased solubility at duodenal pH means what?

A

nothing

the decreased solubility has little consequence as it can all be absorbed in the stomach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

drugs are considered highly soluble when…..

A

the highest dose required dissolves in <250mL water over a pH range 1-7.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

drugs are considered highly permeable if…..

A

90% of the administered dose is absorbed

44
Q

BCS class I

A

high solubility and high permeability

45
Q

BCS class II

A

low solubility

high permeability

46
Q

BCS class III

A

high solubility

low permeability

47
Q

BCS class IV

A

low solubility

low permeability

48
Q 
A weakly basic BCS class II drug has decreased bioavailability when administered in an immediate release oral dosage form. Which ONE of the following is a possible cause of the decreased bioavailability?
A:  Gastric solubility is less than intestinal solubility
B:  The dose was taken with a meal 
C: The drug has poor intestinal permeability
D: Gastric retention time was increased 
E: The dose was taken on an empty stomach
A

E!!!!

A: Gastric solubility is less than intestinal solubility
B: The dose was taken with a meal – increase retention and acidity, this would improve solubility
C: The drug has poor intestinal permeability – doesn’t have this as it has high permeability
D: Gastric retention time was increased – this would improve as it is weakly basic the longer it is in the stomach the better
E: The dose was taken on an empty stomach – decreased solution and therefore decrease bioavailability

49
Q

____% of new compounds are poorly soluble or lipophilic

A

40

50
Q

low drug solubility consequences in the body?

A

Decreased bioavailability
Increased chance of food effects
Increased issues in patients with diseases, especially GIT problems relating to blood flow
More frequent incomplete release of the drug from the dosage form
Higher inter-patient variability

51
Q

low drug solubility problems in formulation?

A

Severely limited choice of delivery technologies
Increasingly complex dissolution testing
Limited or poor correlation with in vivo absorption

52
Q

Newly synthesised drug compounds may have solubility and permeability issues that halt drug development. Which ONE of the following would be LEAST likely in the case of a drug with poor solubility and high permeability?

A: Increased chance of food effects
B: Higher inter-patient variability
C: Limited correlation of dissolution testing with in vivo absorption
D: Increased bioavailability
E: More frequent incomplete release of the drug from the dosage form

A

D!!!

A: Increased chance of food effects
B: Higher inter-patient variability
C: Limited correlation of dissolution testing with in vivo absorption – even a poorly soluble drug is likely to act the same every time.
D: Increased bioavailability – this drug is poorly soluble so you might not get much absorption in the stomach
E: More frequent incomplete release of the drug from the dosage form

53
Q

what is wettability

A

measurement of contact angle

54
Q

what are solid dispersions

A

eutectic mixture with water soluble carriers

55
Q

effect of adsorbents?

A

reduce drug available, unless readily reversible

56
Q

hydro_____ diluents are used for hydrophobic drugs

A

hydrophillic

57
Q

factors that effect solubility and permeability?

A

Wettability – measurement of contact angle
Surfactants – wetting, solubilisation and permeability enhancing
Particle size – smaller size increase effective surface area
Solid dispersions – eutectic mixture with water soluble carrier
Polymorphs – different solubility, melting point and dissolution rate
pH solubility – weak acid and bases vary as a function of pH
Soluble prodrugs – of poorly soluble drug eg nordiazepam replaced with clorazepate, acid degraded to nordiazepam
Complexation – by excipients, GI mucin, food etc
Adsorbents – reduce drug available, unless readily reversible
Viscosity- enhancing agents, complex drug, increase residence time
Degradation – acid or enzymatic hydrolysis (eg Penicillin G, erythromycin) reduce drug available for absorption
Diluents – hydrophilic diluents for hydrophobic drugs

58
Q

major issues caused by poor drug solubility

A

Poor oral bioavailability
Suboptimal dosing
Food effects: variation in bioavailability in fed vs fasting states
Lack of dose response proportionality
Inability to optimise lead compounds
Harsh excipients required e.g. excessive use of co solvents
Use of extreme basic or acidic conditions to enhance solubilisation
Uncontrollable precipitation after dosing
Patient non-compliance due to inconvenience of formulation and/or dosing regimen

59
Q

Cyclodextrins have a hydro______ interior and a hydro ______ exterior

A

PHOBIC

PHILLIC

60
Q

how are cyclodextrins formed?

A

by
Supersaturating a CD solution with drug, with agitation
Kneading a drug/CD/solvent slurry to a paste, which is dried and sieved

61
Q

what improves the solubilising effect of Cyclodextrins? meaning?

A

hydrophilic polymers

so less CD is needed to solubilise the same amount of drug

62
Q

why are there few oral CD based drugs on the market?

A

they have toxicity and stability issues

63
Q

amorphous solid dispersions are _____ soluble

A

more

64
Q

what are amorphous solid dispersions prone to?

A

recrystallisation as they’re more unstable

65
Q

how can amorphous compounds be created?

A

by formulation with polymers

spray dry using solvents

hot melt extrusion

66
Q

what is hot melt extrusion

A

Hot melt extrusion: soften polymer, add drug and mix as the dispersion flows through the extruder; rapidly cool and extrude to form strands of polymeric glass with embedded API; mill glass strands into a powder

67
Q

name 4 types of polar excipients?

A

PEG
gelatin
sugar glasses e.g. insulin
lipids

68
Q

use of liquid PEG in liquid based dosage forms?

A

co-solvent to prevent precipitation of compounds that are poorly soluble in aqueous formulations

69
Q

use of PEG in solid dosage forms?

A

wetting agent or enhances dispersion

incorporated by solvent evaporation or freeze drying

70
Q

what is gelatine, how is it polar?

A

• A naturally derived collagen extract with both positive and negative charges , which bind to the poorly soluble compound

71
Q

what can gelatine be used for?

A

to improve the wettability of hydrophobic compounds when used as a granulating agent

72
Q

what are sugar glasses?

A

A naturally occurring fructose

73
Q

what administration is PEG in liquid dosage forms safe to use?

A

topical and parenteral administration

74
Q

what administration are sugar glasses safe for use?

A

parenteral

pulmonary

75
Q

how can sugar glass be created?

A

Mixing an inulin solution with a drug solution, followed by freeze drying

76
Q

sugar glasses effect on drugs?

A

improve the dissolution profile of the drug and protect it from physical and chemical degradation, increasing stability

77
Q

examples of drugs where sugar glass has been used?

A

Cyclosporin, diazepam, amoxicillin, bacitracin, tetrahydrocannabinol

78
Q

when are lipids used as polar excipients?

A

Lipids are used as polar excipients in self emulsifying systems e.g. lymphatic delivery

79
Q

effect of reducing particle size on dissolution?

A

Reducing particle size increases surface area and usually improved dissolution properties, enabling the use of a wider range of formulations and delivery approaches

80
Q

what is needed for recrystallisation of poorly soluble materials using liquid solvents and anti-solvents to reduce particle size? effect of this

A

organ solvents for processing

means a more complicated manufacture

81
Q

conventional comminution and spray drying rely upon? what is the effect of this?

A

mechanical stress to disaggregate the active compound
This puts significant amounts of stress on the drug product and may induce degradation or thermal stress
This approach is therefore not suitable for thermo-sensitive or unstable compounds

82
Q

what compounds is conventional comminution and spray drying not suitable for?

A

thermo sensitive or unstable compounds

83
Q

why is there higher absorption and dissolution in the SI

A

absorption: higher SA to volume ratio
dissolution: greater transit time- window for absorption

84
Q

benefits of nanoparticle formulations on drug delivery?

A

greater F- higher Cmax and AUC

less variability with food: small difference between fed and fasted F

dose proportionality: AUC proportional to dose

85
Q

TF: comminution e.g. grinding and milling can reduce the particle size sufficiently for nearly insoluble drugs to <0.1mg/mL

A

false, these methods are often incapable of reducing the particle size sufficiently

86
Q

what can micromilling do?

A

may operate down to sub-micron sizes, with physical and thermal stresses

87
Q

what do piston gap methods create?

A

drug nanoparticles through hydrodynamic cavitation

88
Q

how do supercritical fluids create nanoparticles?

A

by control of solubility using pressure and temperature in solvents such as CO2

89
Q

what are supercritical fluids used in?

A

in manufacture as an effective means of producing different sizes and shapes of drug particles.

90
Q

examples of supercritical fluids?

A

CO2 and water

91
Q

what makes CO2 and water supercritical fluids?

A

at a temperature and pressure above their thermodynamic critical points, assume the properties of both a liquids and a gas.

92
Q

properties of SCFs like a gas

properties of SCFs like a liquid

A

can diffuse through solids like a gas

can dissolve materials like liquids

93
Q

how can SCFs reduce particle size?

A

• SCF-solubilised drug particles may be re-crystallised at greatly reduced particle sizes, often 5 – 2000nm in diameter

94
Q

at near critical temperatures SCFs are highly ______. what does this allow.

A

compressible

allowing moderate changes in pressure or temperature to greatly alter their density

95
Q

at near critical temperatures SCFs are highly compressible. what does this allow.

A

allows moderate changes in pressure or temperature to greatly alter their density

96
Q

manipulation of the pressure of SCFs effects?

A

improves diffusivity and reduces viscosity and surface tension

97
Q

Supercritical fluid processes are emerging as alternatives to produce small drug particles by re-crystallization and precipitation processes. Identify which ONE of the following statements is correct:
A: SCFs are poorly compressible and allow large changes in temperature and pressure to be used to maintain density and solvation power
B: SCFs are poorly compressible and maintain uniform density during pressure and temperature changes, allowing good control of particle size
C: SCFs are poorly compressible and allow small changes in temperature and pressure to be used to alter density and solvation power
D: SCFs are highly compressible, allowing small changes in temperature and pressure to alter density and solvation power
E: SCFs are highly compressible, preventing large changes in temperature and pressure from altering their density and solvation power

A

D

98
Q

in self emulsifying systems: non-ionic surfactants improve drugs _______. what does this prevent

A

solubilisation

prevents drugs from precipitating out of the microemulsion

99
Q

what are tweens used for in self emulsifying systems?

A

polysorbates
they have high hydrophile-lipophile balances (HLB) are used to ensure an immediate formation of oil-in-water droplets during production

100
Q

what are co-solvents/ surfactants used for in self emulsifying systems?

A

are used to increase the amount of drug dissolved into the lipid base

PEG, ethanol

101
Q

what’s involved in the preparation of self emulsifying lipid based formulations?

A

involves incorporation of the drug into a oil-surfactant mixture, which is loaded into hard or soft gelatin capsules

102
Q

the presence of lipid in the duodenum stimulates?

A

stimulates secretion of biliary lipids, generating colloidal micelles, mixed micelles and emulsion droplets

103
Q

in self emulsifying lipid based formulations, what is the most important step for the bioavailability?

A

digestion of the lipids

104
Q

in lipid formulations, what interactions promotes solubilisation and absorption of the drug

A

interactions of triglycerides and surfactants with the wall of the GIT

105
Q

how are lipid formulations absorbed? do they undergo first pass?

A

into the intestinal lymphatics- like fats in our diet
then into systemic circulation

they dont undergo first pass

106
Q

LogP of ____ facilitates absorption into the intestinal lymphatics

A

5

107
Q

Which one of the following formulation approaches would be most appropriate to address variable and poor bioavailability upon oral administration, for an amphipathic, weakly basic drug with limited aqueous solubility and which is a known substrate for p-glycoprotein?
A: Delayed release colonic delivery solid dose form to reduce variable absorption in the upper intestine
B: Floating dose form to increase retention time in the stomach
C: Liquid filled capsule releasing a self-microemulsifying lipid formulation predominantly in the small intestine.
D: Complexation with a hydrophilic anionic polymer matrix dosage form that disintegrates in the small intestine
E: Amorphous solid dispersion from a hot melt extrusion formulation micro-milled into small particles to release in the small intestine

A

C!!!

A: Delayed release colonic delivery solid dose form to reduce variable absorption in the upper intestine – solid dosage form only to be released in the colon
B: Floating dose form to increase retention time in the stomach – we do want absorption in stomach but it has limited aqueuous solubility as you won’t get complete dissolution
C: Liquid filled capsule releasing a self-microemulsifying lipid formulation predominantly in the small intestine. - Already dissolved so combated limited solubility. Lipid formulation will also promote absorption
D: Complexation with a hydrophilic anionic polymer matrix dosage form that disintegrates in the small intestine -
E: Amorphous solid dispersion from a hot melt extrusion formulation micro-milled into small particles to release in the small intestine

Medicine Pharmaceutics (6 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions